• 1
    Parkin DM, Ohshima H, Srivatanakul P, Vatanasapt V. Cholangiocarcinoma: epidemiology, mechanisms of carcinogenesis and prevention. Cancer Epidemiol Biomarker Prev 1993; 2: 53744.
  • 2
    Deerasamee S, Martin N, Sontipong S, Sriampon S, Sriplung H, Srivatanakul P, Vatanasapt V, Parkin DM, Ferlay J. Cancer in Thailand Vol. II, 1992–1994 IARC Technical report, vol. 34 Lyon: International Agency for Research on Cancer, 1999. 135.
  • 3
    International agency for research on cancer. Infection with liver flukes (Opisthorchis viverrini, Opisthorchis felineus and Clonorchis sinensis). IARC Monogr Eval Carcinog Risks Hum 1994; 61: 12175.
  • 4
    Sithithaworn P, Haswell-Elkins MR, Mairiang P, Satarug S, Mairiang E, Vatanasapt V, Elkins DB. Parasite-associated morbidity: liver fluke infection and bile duct cancer in northeast Thailand. Int J Parasitol 1994; 24: 83343.
  • 5
    Lang M, Pelkonen O. Metabolism of xenobiotics and chemical carcinogenesis. IARC Sci Publ 1999: 1322.
  • 6
    Strange RC, Fryer AA. The glutathione S-transferases: influence of polymorphism on cancer susceptibility. IARC Sci Publ 1999: 23149.
  • 7
    Parkin DM, Srivatanakul P, Khlat M, Chenvidhya D, Chotiwan P, Insiripong S, L'Agge KA, Wild CP. Liver cancer in Thailand. I. A case-control study of cholangiocarcinoma. Int J Cancer 1991; 48: 3238.
  • 8
    Sripa B, Kaewkes S. Relationship between parasite-specific antibody responses and intensity of Opisthorchis viverrini infection in hamsters. Parasite Immunol 2000; 22: 13945.
  • 9
    Thamavit W, Bhamarapravati N, Sahaphong S, Vajrasthira S, Angsubhakorn S. Effects of dimethylnitrosamine on induction of cholangiocarcinoma in Opisthorchis viverrini-infected Syrian golden hamsters. Cancer Res 1978; 38: 46349.
  • 10
    Thamavit W, Kongkanuntn R, Tiwawech D, Moore MA. Level of Opisthorchis infestation and carcinogen dose-dependence of cholangiocarcinoma induction in Syrian golden hamsters. Virchows Arch B Cell Pathol Incl Mol Pathol 1987; 54: 528.
  • 11
    Tricker AR. N-nitroso compounds and man: sources of exposure, endogenous formation and occurrence in body fluids. Eur J Cancer Prev 1997; 6: 22668.
  • 12
    Mitacek EJ, Brunnemann KD, Suttajit M, Martin N, Limsila T, Ohshima H, Caplan LS. Exposure to N-nitroso compounds in a population of high liver cancer regions in Thailand: volatile nitrosamine (VNA) levels in Thai food. Food Chem Toxicol 1999; 37: 297305.
  • 13
    Swann PF. Effect of ethanol on nitrosamine metabolism and distribution. Implications for the role of nitrosamines in human cancer and for the influence of alcohol consumption on cancer incidence. IARC Sci Publ 1984: 50112.
  • 14
    Anderson LM, Chhabra SK, Nerurkar PV, Souliotis VL, Kyrtopoulos SA. Alcohol-related cancer risk: a toxicokinetic hypothesis. Alcohol 1995; 12: 97104.
  • 15
    Abdel-Rahman SZ, el-Zein RA, Anwar WA, Au WW. A multiplex PCR procedure for polymorphic analysis of GSTM1 and GSTT1 genes in population studies. Cancer Lett 1996; 107: 22933.
  • 16
    Breslow NE, Day NE. Statistical methods in cancer research. Vol. I. The analysis of case-control studies, vol. 32. Lyon: International Agency for Research on Cancer, 1980.
  • 17
    Khoury M, Flanders WD. Nontraditional epidemiologic approaches in the analysis of gene-environmental interaction: case-control studies with no controls! Am J Epidemiol 1996; 144: 20713.
  • 18
    Statacorp. Stata Statistical Software, ed. Release 7.0 College Station, TX: Stata Corporation, 2001.
  • 19
    Pungpak S, Bunnag D, Harinasuta T. Studies on the chemotherapy of human opisthorchiasis: effective dose of praziquantel in heavy infection. Southeast Asian J Trop Med Public Health 1985; 16: 24852.
  • 20
    Coussens LM, Werb Z. Inflammation and cancer. Nature 2002; 420: 8607.
  • 21
    Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet 2001; 357: 53945.
  • 22
    Ohshima H, Bartsch H. Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mutat Res 1994; 305: 25364.
  • 23
    Weitzman SA, Gordon LI. Inflammation and cancer: role of phagocyte-generated oxidants in carcinogenesis. Blood 1990; 76: 65563.
  • 24
    O'Byrne KJ, Dalgleish AG, Browning MJ, Steward WP, Harris AL. The relationship between angiogenesis and the immune response in carcinogenesis and the progression of malignant disease. Eur J Cancer 2000; 36: 15169.
  • 25
    Barton SE, Maddox PH, Jenkins D, Edwards R, Cuzick J, Singer A. Effect of cigarette smoking on cervical epithelial immunity: a mechanism for neoplastic change? Lancet 1988; 2: 6524.
  • 26
    Cantor KP. Drinking water and cancer. Cancer Causes Control 1997; 8: 292308.
  • 27
    Zhang XL, Bing Z, Xing Z, Chen ZF, Zhang JZ, Liang SY, Men FS, Zheng SL, Li XP, Bai XL. Research and control of well water pollution in high esophageal cancer areas. World J Gastroenterol 2003; 9: 118790.
  • 28
    Srivatanakul P, Oshima H, Khlat M, Parkin M, Sukaryodhin S, Brouet I, Bartsch H. Opisthorcis viverrini infestation and endogenous nitrosamines as risk factors for cholangiocarcinoma in Thailand. Int J Cancer 1991; 48: 82125.
  • 29
    Schlesselman JJ. Case-control studies: design, conduct, analysis. Oxford: Oxford University Press, 1982.
  • 30
    Tsuda H, Satarug S, Bhudhisawasdi V, Kihana T, Sugimura T, Hirohashi S. Cholangiocarcinomas in Japanese and Thai patients: difference in etiology and incidence of point mutation of the c-Ki-ras proto-oncogene. Mol Carcinog 1992; 6: 2669.